Synthesis and biodistribution of new oxo and nitrido 99mTc complexes with asymmetrical potentially dianionic or trianionic tetradentate SNNO ligands derived from methyl-2-aminocyclopentene-1-dithiocarboxylic acid

Nuclear Medicine and Biology

Volumn 25, Issue 1, 1998, Pages 65-69

  Belhadj Tahar, H ^a   Ouhayoun, E ^b   Cros, G ^a   Darbieu, M H ^a   Tafani, J A M ^b   Fabre, J ^b   Esquerre, J P ^b   Coulais, Y ^b,c  

^a LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CHU PURPAN   (France)

Author keywords

2 Aminocyclopentene 1 dithiocarboxylic acid; Aminothiol; Biodistribution; Complexes; Nitridotechnetium; Oxotechnetium; Technetium 99m

Indexed keywords

TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG UPTAKE; ISOTOPE LABELING; KIDNEY; LIVER; NONHUMAN; RAT;

ANIMALS; CYCLOPENTANES; DRUG STABILITY; ETHYLENEDIAMINES; HYDROGEN-ION CONCENTRATION; ISOTOPE LABELING; LIGANDS; MALE; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TECHNETIUM COMPOUNDS; TEMPERATURE; THIONES; TISSUE DISTRIBUTION;

EID: 0031986102     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00138-8     Document Type: Article

References (25)

1. 1. Belhadj-Tahar H. (1996) Technetium-99 and rhenium complexes with new polydentate ligands derived from dithiocarboxylic acid: Improvement of oxo and nitrido-technetium radiopharmaceuticals for regional blood flow evaluation. PhD thesis. Grenoble, France.
2. 99mTechnetium complexes. Nucl. Med. Biol. 23, 253-257.
3. 2) technetium-99m complexes: Synthesis and biological evaluation as potential renal radiopharmaceuticais. J. Med. Chem. 36, 1032-1040.
4. 99mTc-labeled aminothiols as possible brain perfusion imaging agents. Nucl. Med. Biol, 15, 215-223.
5. 2 Schiff bases derived from 2 aminocyclopentene-1-dithio-carboxylic acid as potential heart imaging agents. Nucl. Med. Biol. 21, 263-268.
6. 2 unsaturated ligand derived from dithiocarboxylic acid. Inorg. Chim. Acta 227, 25-31.
7. 99mTc-complexes. In: Technetium and Rhenium in Chemistry and Nuclear Medicine (Edited by Nicolini M., Bandoli G. and Mazzi U.), pp. 85-87. Servizi Grafici Editoriali, Padova, Italy.
8. 3 as Hippuran replacement. J. Nucl. Med. 27, 111-116.
9. 188Re labeling of amines and peptides. In: Technetium and Rhenium in Chemistry and Nuclear Medicine (Edited by Nicolini M., Bandoli G. and Mazzi U.), pp. 363-366. Servizi Grafici Editoriali, Padova, Italy.
10. 10. Hansen L., Marzilli L. G., Eshima D., Malveaux E. J., Folks R. and Taylor A. (1994) Evaluation of technetium-99m-triamide-mercaptide complexes designed to identify properties favoring renal tubular transport. J. Nucl. Med. 35, 1198-1205.
11. 11. Hjelstuen O. K. (1995) Technetiutn-99m chelators in nuclear medicine. Analyst 120, 863-866.
12. 12. John C. S., Kung M. P., Billings J. and Kung H. F. (1991) Preparation, radiolabeling and biodistribution of new class of bisaminothiol (BAT) ligands as possible imaging agents. Nucl. Med. Biol. 5, 551-556.
13. 13. Johnson G., Nguyen K. N., Pasqualini R. and Okada R. D. (1997) Interaction of technetium-99m-NOET with blood elements: Potential mechanism of myocardial redistribution. J. Nucl. Med. 38, 138-143.
14. 14. Kasina S., Fritzberg A. R., Johnson D. L. and Eshima D. (1986) Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticals. J. Med. Chem. 29, 1933-1940.
15. 15. Leveille J., Demonceau G. and Walovitch R. C. (1992) Intrasubject comparison between technetium-99m-ECD and technetium-99m-HM-PAO in healthy human subjects. J. Nucl. Med. 33, 480-484.
16. 16. Lever S. Z., Sun S. Y., Scheffel U. A., Kaltovich F. A., Baidoo K. E., Goldfarb H. and Wagner H. N. (1994) Pulmonary accumulation of neutral diamine dithiol complexes of technetium-99m. J. Pharm. Sci. 83, 802-809.
17. 99mTc-radiopharmaceuticals containing the Tc≅N multiple bond. Appl. Radiat, Isot. 43, 1329-1333.
18. 2] (NOET = N-ethyl-N-ethoxydithiocarbamato). J. Chem. Soc. Chem. Commun., 1354-1355.
19. 19. Pasqualini R., Duatti A., Bellande E., Comazzi V., Brucato V., Hoffschir D., Fagret D. and Comet M. (1994) Bis(dithiocarbamato) nitrido technetium-99m radiopharmaceuticals: A class of neutral myocardial imaging agents. J. Nucl. Med. 37, 334-341.
20. 20. Pillai M. R. A., John C. S., Lo J. M., Troutner D. E., Corlija M., Volkert W. A. and Holmes R. A. (1993) Technetium complexes of pentadentates amine-phenol ligands. Nucl. Med. Biol. 20, 211-216.
21. 21. Shiba K., Mori H., Matsuda H., Tsuji S., Kinuya K. and Hisada K. (1991) Synthesis of technetium-99m labeled diaminodithiol for bifunctional chelating agents. Appl. Radiat, Isot. 42, 1159-1164.
22. 22. Srivastava S. C. and Mease R. C. (1991) Progress in research on ligands, nuclides and techniques for labeling monoclonal antibodies. Nucl. Med. Biol. 18, 589-603.
23. 3 and iodine-125-OIH. J. Nucl. Med. 35, 1951-1958.
24. 99mTc-labelled agents. Nucl. Med. Biol. 22, 325-338.
25. 25. Walovitch R. C., Hill T. C., Garrityet S. T., Cheesman E. H., Burgess B. A., O'Leary B. A., Watson A. D., Ganey M. V., Morgan R. A. and Williams S. J. (1989) Characterization of technetium-99m-L, L-ECD for brain perfusion imaging. I. Pharmacology of technetium-99m-ECD in nonhuman primates. J. Nucl. Med. 30, 1892-1901.